A 55-year-old patient with chronic heart failure is admitted to the medical unit with acute exacerbation. The patient has been experiencing worsening symptoms over the past 3 days, including increased shortness of breath, fatigue, and swelling in the legs. The patient presents with severe dyspnea, bilateral crackles, jugular venous distension, and 3+ pitting edema in both lower extremities. Vital signs: BP 160/95 mmHg, HR 110 bpm, RR 28/min, O2 sat 88% on room air. Laboratory results show BUN 45 mg/dL, creatinine 1.8 mg/dL, and potassium 3.2 mEq/L. The physician orders furosemide 40 mg IV push. What is the priority nursing intervention immediately after administering the furosemide?

Monitoring urine output and electrolytes is priority after furosemide due to rapid fluid shifts and risk of imbalances like hypokalemia, especially with pre-existing low potassium. Other interventions (BP monitoring, positioning) are important but secondary to immediate fluid/electrolyte assessment.

Understanding the Clinical Scenario

This patient with chronic heart failure is presenting with classic signs and symptoms of acute decompensated heart failure (ADHF) with significant volume overload. The assessment findings of bilateral crackles, jugular venous distension (JVD), and 3+ pitting edema indicate severe systemic and pulmonary congestion. The vital signs—BP 160/95 mmHg, HR 110 bpm, RR 28/min, and O2 sat 88%—reflect a compensatory sympathetic response to a low cardiac output state and significant respiratory compromise from pulmonary edema. The laboratory values reveal prerenal azotemia (BUN 45 mg/dL, creatinine 1.8 mg/dL) and hypokalemia (potassium 3.2 mEq/L), which are critical safety considerations when administering a loop diuretic like furosemide.

Why Monitoring Urine Output and Assessing for Imbalances is the Priority

The core therapeutic goal in ADHF is decongestion, and loop diuretics are the first-line treatment to achieve this by promoting sodium and water excretion ^[1][3]. Immediately after administering IV furosemide, the nurse's priority is to evaluate the drug's therapeutic and adverse effects, which are directly linked to the patient's renal function and pre-existing electrolyte abnormalities.

1. Evaluating Therapeutic Efficacy and Diuretic Resistance: The primary reason for giving furosemide is to relieve congestion. The most direct and quantifiable measure of its initial effect is urine output. A robust response confirms that the kidneys are responding to the diuretic. However, up to one-third of patients with heart failure exhibit diuretic resistance (DR), an inadequate natriuretic response that is strongly associated with prolonged hospitalization and adverse outcomes ^[3]. This patient’s elevated BUN and creatinine are red flags for impaired renal perfusion and possible intrinsic renal dysfunction, which are key mechanisms of DR ^[3]. Without close monitoring of urine output, the nurse cannot quickly identify if the patient is not responding, a situation that would require prompt notification of the physician for potential dose adjustment or a change in strategy, such as a continuous infusion .

2. Detecting and Preventing Critical Electrolyte Imbalances: The patient’s baseline potassium is already dangerously low at 3.2 mEq/L. Furosemide works by blocking the sodium-potassium-chloride cotransporter in the thick ascending limb of the loop of Henle, which causes a massive loss of potassium in the urine. Administering a potent loop diuretic to a hypokalemic patient creates an imminent risk of life-threatening cardiac arrhythmias. Monitoring urine output is the first step in assessing the magnitude of these expected losses. This assessment must be immediately paired with evaluating for clinical signs of imbalances, such as muscle weakness, cardiac rhythm changes, and further electrolyte shifts. While other options are important, they do not directly address the immediate, drug-induced risk of worsening hypokalemia in the context of evaluating the drug's primary effect.

Analyzing the Other Options

- Option 1 (Monitor blood pressure): Monitoring BP is important because furosemide can cause hypotension from rapid fluid shifts. However, this patient is currently hypertensive (160/95 mmHg). The more immediate threat is not hypotension but the failure to decongest and the exacerbation of hypokalemia. BP monitoring is a secondary, though still critical, safety parameter.
- Option 2 (Assess lung sounds): Assessing lung sounds is essential for evaluating the resolution of pulmonary congestion, a key goal of therapy. However, changes in lung sounds are a delayed and less quantifiable indicator of diuretic efficacy compared to hourly urine output. The physiological effect of the drug on the kidneys is immediate, while the redistribution of fluid from the lungs takes time.
- Option 4 (High Fowler's position): Positioning the patient in high Fowler's position is an independent, non-pharmacological intervention to immediately improve ventilation and oxygenation. This should be done concurrently and is a priority for the patient's presenting symptom of severe dyspnea with an O2 sat of 88%. However, the question asks for the priority intervention immediately after administering the furosemide. At that moment, the nursing focus must shift to monitoring the effects of the medication just given, which directly informs the next steps in the patient's decongestion plan ^[1].

The combination of severe congestion, pre-existing renal impairment, and critical hypokalemia makes monitoring the patient's response to furosemide—starting with urine output and a thorough imbalance assessment—the most time-sensitive and safety-critical nursing action to prevent further clinical deterioration.